Ascendis Pharma A/S (ASND) is in Healthcare, Biotechnology, based in Denmark, listed on NasdaqGS. Market cap 14.65B USD. 52-week range 186.05 to 282.15 USD. Trailing P/E 17.1. Data as of 2026-10-09.
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in ...